Market Access Transformation, a Genesis Research company
Dominic Jones-Phillips has extensive experience in market access and healthcare consulting. Dominic is currently working at Market Access Transformation as the Director of Market Access Operations and Head of Payer Engagement. Dominic has been with the company since 2018 and has held various roles, including Director and Associate Director. Prior to joining Market Access Transformation, Dominic worked as a Senior Market Access Consultant at Valid Insight from 2016 to 2018. Dominic also served as the Market Access Director at Apex Healthcare Consulting for a brief period in 2016. Before entering the consulting field, Dominic worked as a Project Manager at DRG Abacus from 2011 to 2015, where they held roles such as Consultant Project Manager, Account Executive, Senior Research Analyst, and Research Analyst in the Payer Insight and Reimbursement Strategy unit. Dominic's career began in 2004 at Syngenta CTL, where they worked as a Student Research Scientist while studying for their BSc in Biochemistry.
Dominic Jones-Phillips completed their Bachelor of Science degree in Biochemistry from the University of York, from 2002 to 2006. Dominic then pursued further studies at the same institution and received a Master of Research degree in Functional Genomics from 2006 to 2007. Following this, they enrolled in the University of Leeds, where they obtained a PhD in Experimental Rheumatology from 2007 to 2010.
This person is not in any offices
Market Access Transformation, a Genesis Research company
**May 2022 Genesis Research acquired Marketing Access Transformation** Founded in 2016, Market Access Transformation (MAT) specializes in developing agile technology platforms that enable the healthcare community to exchange insights that asses the real-world potential of their pharmaceutical products. With close to 65 employees that span the US, UK and India, MAT is seen as a revolutionary company in the global pharmaceutical research space. Our primary platform, Rapid Payer Responses™ (RPR), enables pharmaceutical manufacturers to conduct critical market access research throughout the product and treatment development process. Through our global, vetted payer network, it is possible to gather more accurate, robust feedback and insights by probing further and asking deeper questions. you always have the exact answers you need in a fraction of the time and cost of a traditional payer research project. Our life science experts help facilitate this process, monitoring the responses in real time as they come in for quality and detail. Since the launch of Rapid Payer Response™ (RPR) in July 2016, we have partnered with over 50 of the leading pharmaceutical manufacturers, expanded our payer network to more than 45 countries and have achieved an impressive 93% license renewal rate as we continue to disrupt the older and outdated models for payer research. Were are diverse minded, global company with offices in the US (NJ, NY & CA), UK and India. If you are interested in joining our amazing MAT team, check our openings at https://www.marketaccesstransformation.com/careers